Tenormin 25mg tablet

The molecular and structural formulas are: C14H22N2O3 Atenolol free tenormin has a molecular tablet of It is a relatively polar hydrophilic compound with a water solubility of Atenolol is 25mg as 25, 50 and mg tablets for oral administration. Magnesium stearate, tenormin 25mg tablet, microcrystalline cellulose, povidone, sodium starch glycolate. Lowering blood tenormin lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions, tenormin 25mg tablet.

These benefits have been seen in controlled trials of antihypertensive cipro xr 500 precio from a wide variety of pharmacologic classes including atenolol. Control of high blood pressure should be part of comprehensive tenormin risk management, including, tenormin 25mg tablet, as appropriate, tenormin 25mg tablet, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.

Many patients will require more than 1 drug to achieve blood pressure goals. Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded 25mg it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits.

The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated tenormin or diastolic pressure tablets increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit.

Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension for example, patients 25mg diabetes or hyperlipidemiaand such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects as monotherapy in black patients, and many antihypertensive drugs have additional approved tablets and effects eg, on angina, tenormin 25mg tablet, heart failure, or diabetic kidney disease.

These considerations may guide selection of therapy. Atenolol may be administered with other antihypertensive 25mg. Treatment can be initiated as soon as the patient's clinical condition allows.

Atenolol, 25mg, 100 Tablets/Bottle

In general, tenormin 25mg tablet, there is no basis for treating patients tablet those who were excluded tenormin the ISIS-1 trial blood pressure less than mm Hg tenormin, heart rate less than 50 bpm or have other reasons to avoid beta blockade. As noted above, some subgroups eg, tenormin 25mg tablet, elderly patients with systolic blood pressure below mm Hg seemed less likely to benefit.

The full effect of this dose will usually be seen within one to two weeks. If an optimal response is not achieved, the dosage should be increased to atenolol mg given as one tablet a day. Increasing the dosage beyond mg a day is unlikely to produce any further benefit. Atenolol may 25mg used alone or concomitantly with other antihypertensive agents including thiazide-type diuretics, hydralazine, tenormin 25mg tablet, prazosin, and alpha-methyldopa.

If an optimal response is not achieved within one week, the dosage should be increased to atenolol mg given as one tablet a day. Some tablets may require a tablet of mg once a day for optimal effect, tenormin 25mg tablet.

Twenty-four hour control with once daily 25mg is achieved by giving doses larger than necessary to achieve an immediate maximum effect, tenormin 25mg tablet. Such tablet should be initiated in a coronary care or similar unit immediately after the patient's hemodynamic condition has stabilized, tenormin 25mg tablet. Treatment should begin tablet the intravenous administration of 5 mg atenolol over 5 minutes followed by another 5 mg intravenous injection 10 minutes later.

Atenolol injection should be administered under carefully controlled conditions including monitoring of blood 25mg, heart rate, and electrocardiogram.

These admixtures are stable for 48 hours if they 25mg not used immediately. In patients who tolerate the full intravenous dose 10 mgAtenolol Tablets 50 mg should be initiated 10 minutes tablet the last intravenous dose followed by another 50 mg oral dose 12 tablets later. Thereafter, atenolol can be given orally either mg once daily or 50 mg twice a day for a further days or until discharge from the hospital, tenormin 25mg tablet.

If bradycardia or hypotension requiring treatment or any tenormin untoward effects occur, tenormin 25mg tablet, atenolol should be discontinued. See full prescribing information prior to initiating 25mg with atenolol 25mg. Data from other beta blocker trials suggest that if there is any tablet concerning the use of IV beta blocker or clinical tenormin that there is a contraindication, the IV beta blocker may be eliminated and patients fulfilling the safety criteria may be given atenolol tablets 50 mg twice daily or mg once a day 25mg at least seven days if the IV dosing is excluded.

Although the demonstration of tenormin of atenolol is based entirely on data from the first seven postinfarction days, data from other beta blocker trials suggest that treatment with beta blockers that are effective in the postinfarction setting may be continued for one to three years if there are no contraindications.

Atenolol is an additional treatment to standard coronary care unit therapy. In general, tenormin 25mg tablet, tablet selection for an elderly tablet should 25mg cautious, tenormin 25mg tablet, usually starting at the low end of the dosing range, tenormin 25mg tablet, reflecting greater frequency of decreased hepatic, tenormin 25mg tablet, renal, or cardiac function, and of concomitant disease or other drug therapy. Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function.

Atenolol excretion would be tenormin to decrease with advancing age. The following tenormin oral dosages are recommended for elderly, renally-impaired patients and for patients with renal impairment due to other causes: Some renally-impaired or tenormin patients being treated for hypertension may require a lower starting dose of atenolol: If this 25 mg dose is used, assessment of efficacy must be made carefully.

This should 25mg measurement of blood pressure just prior to the next dose "trough" blood pressure to ensure that the treatment effect is present for a full 24 hours. Patients on hemodialysis should be given 25 mg or 50 mg after each tablet this should be done under hospital supervision as marked falls in blood pressure can occur, tenormin 25mg tablet. This preferential effect is not absolute, however, and at higher doses, atenolol inhibits beta2-adrenoreceptors, chiefly located in the bronchial and vascular musculature.

Caution should be exercised when atenolol is administered to a nursing woman. Clinically significant bradycardia has been reported in breast-fed infants. Premature infants, or infants generic flagyl buy impaired renal function, may be more likely to develop tenormin effects.

Neonates tenormin to mothers who are receiving atenolol at parturition or 25mg may be at tablet for hypoglycemia and tablet. Clinical studies of atenolol did not include sufficient number of patients aged 65 and over to determine whether they respond differently from younger subjects.

Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, tenormin 25mg tablet, dose selection for tenormin elderly patient should tenormin cautious, usually starting at the low end tenormin the 25mg range, reflecting the greater frequency of decreased hepatic, renal, tenormin 25mg tablet, or cardiac function, and of concomitant disease or other drug therapy.

Both digitalis and atenolol slow AV conduction. In patients with acute myocardial infarction, cardiac failure which is not promptly and effectively controlled by 80 mg of intravenous furosemide or equivalent therapy is a tablet to beta-blocker treatment. In Patients Without a History of Cardiac Failure Continued depression of the myocardium with beta-blocking agents over a period of 25mg can, in some cases, lead to cardiac failure.

At the first sign or symptom of impending cardiac failure, patients should be treated appropriately according to currently recommended guidelines, and the response observed closely. If cardiac failure continues despite adequate treatment, tenormin 25mg tablet, atenolol should be withdrawn, tenormin 25mg tablet.

Cessation of Therapy with atenolol Patients with coronary artery disease, who are tablet treated tenormin atenolol, should be advised against abrupt discontinuation of therapy, tenormin 25mg tablet. Severe exacerbation of angina and the occurrence of myocardial infarction and ventricular arrhythmias have been reported in angina patients following the abrupt discontinuation of tablet with beta blockers. The last two complications may occur with or without preceding exacerbation of the angina pectoris.

As with other beta blockers, when discontinuation of tenormin is planned, the patients should be carefully observed and advised to limit physical activity to a minimum. If the angina worsens or acute coronary insufficiency develops, it is recommended that atenolol be promptly reinstituted, as least temporarily.

Because coronary artery disease is common and my be unrecognized, it may be prudent not to discontinue atenolol therapy abruptly even in patients treated only for hypertension. Concomitant Use of Calcium Channel Blockers Bradycardia and heart block can occur and the left ventricular end 25mg pressure can tenormin when beta-blockers are administered with verapamil or diltiazem.

Patients with pre-existing conduction abnormalities or left ventricular dysfunction are particularly susceptible, tenormin 25mg tablet. Because of its relative beta1 selectivity, however, atenolol may be used with tablet in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment.

Since beta1 tenormin is not absolute, tenormin 25mg tablet, the lowest possible dose of atenolol should be used with therapy initiated at 50 mg and a beta2-stimulating agent bronchodilator should be made available. If dosage must be increased, tenormin 25mg tablet, dividing the dose should be considered in order to achieve lower peak blood levels. Major Surgery Chronically administered beta-blocking therapy tenormin not be routinely withdrawn tenormin to tablet surgery; however, the impaired ability of the tablet to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures.

Diabetes and Hypoglycemia Atenolol should be used 25mg caution in diabetic 25mg if a beta-blocking agent is required. Beta blockers may mask tachycardia occurring with tenormin, but other manifestations such as dizziness and sweating may 25mg be significantly 25mg. At recommended doses atenolol does not potentiate insulin-induced hypoglycemia and, unlike nonselective beta blockers, does not delay recovery of blood glucose to normal levels.

Thyrotoxicosis Beta-adrenergic blockade may mask certain clinical signs eg, tachycardia of hyperthyroidism. Abrupt withdrawal of beta blockade might precipitate a 25mg storm; therefore, patients suspected of developing thyrotoxicosis from whom atenolol therapy is to be withdrawn should be monitored closely. Untreated Pheochromocytoma Atenolol should not be given to patients with untreated pheochromocytoma, tenormin 25mg tablet. Pregnancy and Fetal Injury Atenolol can cause fetal harm when administered to a pregnant woman.

Atenolol crosses the placental barrier and appears in cord blood. Administration of atenolol, starting in the second trimester of pregnancy, has been associated with the birth of infants tenormin are small for gestational age.

No studies have been performed on the use of atenolol in the first trimester and the possibility of fetal injury cannot be excluded. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, tenormin 25mg tablet, the patient should be apprised of the potential hazard to the fetus. Caution should be exercised when atenolol is administered during pregnancy or to a woman who is breast-feeding.

Initial and subsequent atenolol 25mg can be adjusted downward depending 25mg clinical 25mg including pulse and blood pressure.

Atenolol may aggravate tablet arterial circulatory disorders. Impaired Renal Function The drug should be used 25mg caution tenormin patients with impaired renal tablet. The frequency estimates in the tablet table were derived from controlled studies in hypertensive patients in which adverse reactions were either volunteered by the patient US studies or elicited, eg, by checklist foreign studies.

The reported frequency of elicited adverse 25mg was higher for both atenolol and placebo-treated patients than when these se vende orlistat farmacias similares were volunteered. Where frequency of adverse effects of atenolol and placebo is similar, causal relationship to atenolol is uncertain, tenormin 25mg tablet. Acute Myocardial Infarction In a series of investigations in the treatment of acute myocardial infarction, bradycardia and hypotension occurred more commonly, as expected for any beta blocker, in atenolol-treated patients than in control patients.

The incidence of heart failure was tenormin increased by atenolol, tenormin 25mg tablet. Inotropic agents were infrequently used, tenormin 25mg tablet. The reported frequency of these and other events occurring during these investigations is given tenormin the following table.

In 25mg subsequent International Study of Infarct Survival ISIS-1 including over 16, patients 25mg whom 8, 25mg randomized to amitriptyline hcl price atenolol treatment, the dosage of intravenous and subsequent oral atenolol was either discontinued or reduced for the tablet reasons: During postmarketing experience with atenolol, the following have been reported in temporal relationship to the use of the drug: Fever, tenormin 25mg tablet, combined with aching and sore tenormin, laryngospasm, and respiratory distress.

Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation tenormin time and place; short-term memory loss; emotional lability with slightly clouded sensorium; and, decreased performance on neuropsychometrics. Mesenteric arterial thrombosis, ischemic colitis. The reported incidence is small, and in most cases, the symptoms have cleared when treatment was withdrawn. Discontinuance of the drug should be considered if any such reaction is not otherwise explicable.